Plunkett Research Online: Mayne Pharma Group

MAYNE PHARMA GROUP (MAYNF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Mayne Pharma Group is a specialty pharmaceutical company engaged in the development, manufacture and in-licensing of branded and generic products for direct distribution or via partners into the United States and Australia. It also has a fee-for-service contract development and manufacturing divisio.....



Mayne Pharma Group
Ticker: MAYNF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 61 386147777
Fax: 61 396147022
Address: 1538 Main North Road
Salisbury South
Salisbury, SA 5106 Australia

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription

Mayne Pharma Group is a specialty pharmaceutical company engaged in the development, manufacture and in-licensing of branded and generic products for direct distribution or via partners into the United States and Australia. It also has a fee-for-service contract development and manufacturing divisio.....See More See More

Auditor: ERNST & YOUNG
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: